Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
5650studies shown
Showing 3,205-3,216 of 5,650
Drug study icon
RecruitingNCT05883540

Lysergic Acid Diethylamide (LSD) in Palliative Care

This study is comparing Lysergic Acid Diethylamide Tartrate with control arm for people with depression or anxiety. Participants receive Lysergic Acid Diethylamide Tartrate or control arm and complete study visits and assessments.

Multiple locations, including Basel
Anxiety, DepressionDrugA study involving a medication or substance.Over 22 Years
Countries
Switzerland
Sponsor
University Hospital, Basel, Switzerland
Condition
Anxiety, Depression
Behavioral study icon
RecruitingNCT06526143

M2VA Pain Care Pathway

This summary needs review. Please check the official study record and contact the research team for details.

In West Haven
AddictionBehavioralOver 18 Years
Countries
United States
Sponsor
Yale University
Condition
Addiction
Other study type icon
RecruitingNCT06412562

M3VAS Validation in Polish Population

This observational study is following people with depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Gdansk
DepressionDiagnostic TestA study that looks at how to detect, measure, or better understand a condition.Over 18 Years
Countries
Poland
Sponsor
Medical University of Gdansk
Condition
Depression
Behavioral study icon
RecruitingNCT06350201

Machine Learning-based Classification of Symptom Clusters and Online CBT

This study is looking at whether a digital support tool can help people with Depression and Anxiety Symptom. Participants take part in a digital support tool and complete follow-up assessments.

In Wuhan
Anxiety, DepressionBehavioralFrom 18 Years to 64 Years
Countries
China
Sponsor
Wuhan Mental Health Centre
Condition
Anxiety, Depression
Other study type icon
RecruitingNCT07633080

Magnesium Bisglycinate in Major Depressive Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In Bhubaneswar
DepressionOtherFrom 18 Years to 65 Years
Countries
India
Sponsor
All India Institute of Medical Sciences, Bhubaneswar
Condition
Depression
Device study icon
RecruitingNCT07113665

Magnetic Resonance-Guided Focused Ultrasound Bilateral Capsulotomy for Refractory Eating disorders With Comorbid OCD or Major Depressive Disorder

This study is looking at whether a digital support tool can help people with Eating disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In Toronto
Depression, Eating disorders, ...DeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
Countries
Canada
Sponsor
Sunnybrook Health Sciences Centre
Condition
Depression, Eating disorders, ...
Device study icon
RecruitingNCT07108257

Magnetic Resonance-Guided Focused Ultrasound Bilateral Capsulotomy for Refractory Depression in bipolarity

This study is looking at whether a digital support tool can help people with Treatment-Resistant Depression or Depression in bipolarity. Participants receive a study treatment and complete follow-up visits and assessments.

In Toronto
Bipolarity, DepressionDeviceFrom 18 Years to 65 Years
Countries
Canada
Sponsor
Sunnybrook Health Sciences Centre
Condition
Bipolarity, Depression
Drug study icon
RecruitingNCT06581302

Magnetic Seizure Therapy for Psychotic Disorders

This study is looking at whether Magnetic seizure therapy by Magnetic stimulator can help people with psychosis. Participants receive a study treatment and complete follow-up visits and assessments.

In Shanghai
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
China
Sponsor
Shanghai Jiao Tong University School of Medicine
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT06672588

Magnetic Seizure Therapy for Schizophrenia - study

This study is looking at whether Magnetic Seizure Therapy (MST) can help people with Treatment Resistant Schizophrenia, Schizophrenia, or schizoaffective disorder. Participants take part in Magnetic Seizure Therapy (MST) and complete follow-up assessments.

Multiple locations, including Vancouver
SchizophreniaBehavioralOver 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.